<DOC>
	<DOCNO>NCT01829880</DOCNO>
	<brief_summary>The purpose study determine cachexia change body composition influence pharmacokinetics bisoprolol ramipril accuracy equation renal function estimation .</brief_summary>
	<brief_title>Impact Body Composition Bisoprolol Ramipril Pharmacokinetics Patients With Chronic Heart Failure</brief_title>
	<detailed_description>Patients chronic heart failure treatment bisoprolol and/or ramipril include . Study consist two study visit : baseline visit ( V1 ) visit perform least 6 month baseline ( V2 ) . At visit procedure perform . On day visit , patient ask take morning dose bisoprolol and/or ramipril withdrawal first morning plasma sample . Additional 3 5 plasma sample take within 5 hour post bisoprolol and/or ramipril dose order determine pharmacokinetic profile drug . Body composition measure bioimpedance dual-energy X-ray absorptiometry . Renal function measure clearance intravenously administer iohexol . Biochemical parameter , muscle strength , fatigue anorexia assess order determine presence cachexia . Changes body composition correlate change pharmacokinetic parameter bisoprolol ramipril . Pharmacokinetic parameter cachectic patient compare pharmacokinetic parameter non-cachectic patient . Parameters body composition correlate difference measure estimate renal function .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<criteria>Diagnosis chronic heart failure New York Heart Association Functional Classification ( NYHA ) class II III On treatment bisoprolol least 3 day and/or ramipril least 4 day V1 Able willing provide freely give write informed consent Chronic renal disease estimate glomerular filtration rate calculate Modification Diet Renal Disease ( MDRD ) equation &lt; 40 mL/ ( min x 1,73 m2 ) V1 V2 Liver disease increase serum liver enzyme ( bilirubin &gt; 1.5 x normal , gammaglutamyl transpeptidase ( GGT ) &gt; 2.5 x normal , aspartate transaminase ( AST ) &gt; 2.5 x normal , alanine transaminase ( ALT ) &gt; 2.5 x normal ) V1 V2 Absence bisoprolol ramipril steady state concentration V1 V2 withdrawal bisoprolol and/or ramipril inbetween visit Acute decompensation heart failure le 4 week V1 V2 Addition , withdrawal change dose drug importantly influence bisoprolol ramipril pharmacokinetics inbetween V1 V2 Unable understand comply protocol give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Chronic heart failure</keyword>
	<keyword>Bisoprolol</keyword>
	<keyword>Ramipril</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Cachexia</keyword>
	<keyword>Body composition</keyword>
	<keyword>Renal function</keyword>
	<keyword>Iohexol</keyword>
</DOC>